Pharma & Biotech

Eli Lilly & Company's stock posted significant gains, outperforming the broader pharmaceutical sector, following two major announcements. The company secured...

In a year marked by significant revenue declines for major players in the mRNA and COVID-19 vaccine space, BioNTech SE...

Biopharmaceutical firm Ocugen is transitioning from clinical development to the regulatory phase, with its lead gene therapy candidate approaching a...

Market experts are growing more optimistic about Cardiff Oncology's financial trajectory. Following the biotechnology firm's stronger-than-anticipated performance in February, analysts...

Investors in the biotech sector are closely monitoring Ocular Therapeutix as it advances through a pivotal stage of its clinical...

The proposed merger between Rallybio and the private firm Candid Therapeutics has drawn the attention of U.S. legal firms, casting...

For investors in Achieve Life Sciences, all roads lead to a single date: June 20, 2026. This is the deadline...

Vivani Medical finds itself balancing promising clinical developments against financial market realities. The biotechnology firm is targeting the high-growth weight-loss...

BioNxt Solutions has unveiled a strategic pivot designed to position the company at the forefront of one of the pharmaceutical...

Roche has secured significant regulatory approvals across two major markets, delivering a strategic boost to its high-margin diagnostics business. The...